An interventional study of Receipt of ambient listening-generated draft clinical note in Documentation of Serious Illness Communication for Critically Ill Patients, sponsored by University of Pennsylvania. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by University of Pennsylvania · Not applicable, Interventional, and Health services research
The goal of this clinical trial is to learn whether ambient listening can help healthcare providers create written summaries of conversations with the families of patients in the medical intensive care unit (ICU). Ambient listening is an artificial intelligence-enabled tool that records a medical visit and creates a written summary. Healthcare providers already use this technology for many types of appointments. The main questions this trial aims to answer are: Do patients, families, and healthcare providers feel comfortable using ambient listening to record and summarize ICU family meetings? and How much do healthcare providers use content created by ambient listening when it is available to them? and Can ambient listening generate useful summaries of family meetings for patients and their families? Researchers will compare clinical summaries written using an AI-enabled tool to summaries written without the tool to see if using ambient listening makes summaries clearer and more useful to healthcare providers.
Participants will:
Allow researchers to record and transcribe a family meeting with the patient's ICU medical team.
719 studies on the registry are indexed under Communication; 159 are open to participants now.
This study's planned enrollment of 30 is below the median of 144 across 571 interventional studies indexed under Communication.
Browse Communication studies →University of Pennsylvania is the lead sponsor of 1,668 studies on the registry; 235 are open to participants now.
Of its 158 completed or terminated interventional studies of FDA-regulated products, 109 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Clinicians receive draft clinical note generated by ambient listening.
Behavioral: Receipt of ambient listening-generated draft clinical note
Clinicians do not receive draft clinical note generated by ambient listening.
Intervention-arm clinicians will receive a draft structured clinical note generated by ambient listening technology immediately following the scheduled family meeting and may choose to use this draft content when creating their final signed note in the patient's medical record.
Proportion of approached surrogates agreeing to enroll
Acceptability of enrollment: Proportion of approached surrogate decision makers who agree to enroll.
Time frame: At enrollment
Proportion of clinicians utilizing summary content
Feasibility: Proportion of intervention-arm clinicians who access the ambient listening-generated summary and the proportion of overlap between the draft summary and the final signed note.
Time frame: 1 day after intervention
Clinical documentation quality rating
Ratings by an independent panel of clinician reviewers, assessing quality of each extracted clinical note (composite of completeness, clarity, and clinical utility).
Time frame: Up to 6 months after intervention
Proportion of clinicians finding patient- and family-facing summaries acceptable
Acceptability of patient- and family-facing summaries: Whether clinicians would be comfortable with an ambient listening-generated, patient- and family-facing summary of the meeting being provided to the patient and family, either as-generated or with clinician edits.
Time frame: 1 week after intervention
Plan to share: Yes — Deidentified clinical notes; demographic and clinical data; associated scores and responses from clinicians for each note.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Start date: After publication of scientific manuscript. End date: Five years after publication.
Access criteria: Researchers whose proposed use of the data has been approved may access the IPD and supporting information for research purposes specified in their approved proposal. Data will be made available after proposal approval by contacting the study principal investigator.
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.